This study explored the possibility that Antibe’s lead drug, ATB-346, would be effective in a murine model of hereditary intestinal cancer (APCMin+ mouse). Daily treatment with ATB-346 was significantly more effective at preventing intestinal polyp formation than naproxen. Significant beneficial effects were seen with a treatment period of only 3–7 days, and reversal of existing polyps was observed in the colon. ATB-346 may represent a promising agent for chemoprevention of tumorigenesis in the GI tract and elsewhere.
This is an external link. Click “OK” to continue.